{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T10:10:38Z","timestamp":1677147038427},"reference-count":100,"publisher":"Georg Thieme Verlag KG","issue":"03","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tierarztl Prax Ausg G Grosstiere Nutztiere"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>In den letzten Jahren haben zellbasierte Therapeutika zur Behandlung von Osteoarthritiden in der Pferdemedizin einen regelrechten Boom erlebt. In der Praxis werden diese Therapeutika in Eigenverantwortung des Tierarztes aus Patientenblut oder anderen k\u00f6rpereigenen Geweben wie Fettgewebe oder Knochenmark hergestellt. Auch wenn diesen zellbasierten Therapiemethoden das einheitliche therapeutische Konzept der regenerativen Medizin gemein ist, unterscheiden sie sich ma\u00dfgeblich hinsichtlich Herstellungsverfahren, Inhaltsstoffen und Funktionsweisen. Grundlegendes Wissen hierzu erm\u00f6glicht es dem praktizierenden Tierarzt, das f\u00fcr ihn und seine Pferdepatienten geeignete Produkt auszuw\u00e4hlen und bestm\u00f6gliche Behandlungsstrategien zu erstellen.<\/jats:p>","DOI":"10.1055\/a-1482-7752","type":"journal-article","created":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T22:32:46Z","timestamp":1624401166000},"page":"189-202","source":"Crossref","is-referenced-by-count":1,"title":["Zellbasierte Therapeutika zur Behandlung der Osteoarthritis beim Pferd"],"prefix":"10.1055","volume":"49","author":[{"given":"Susanne P.","family":"Roth","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Pferde, Veterin\u00e4rmedizinische Fakult\u00e4t, Universit\u00e4t Leipzig"},{"name":"S\u00e4chsischer Inkubator f\u00fcr Klinische Translation, Universit\u00e4t Leipzig"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Brehm","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Pferde, Veterin\u00e4rmedizinische Fakult\u00e4t, Universit\u00e4t Leipzig"},{"name":"S\u00e4chsischer Inkubator f\u00fcr Klinische Translation, Universit\u00e4t Leipzig"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Troillet","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Pferde, Veterin\u00e4rmedizinische Fakult\u00e4t, Universit\u00e4t Leipzig"},{"name":"S\u00e4chsischer Inkubator f\u00fcr Klinische Translation, Universit\u00e4t Leipzig"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2021,6,22]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.2042-3306.2010.00361","article-title":"Disease prevalence in geriatric horses in the United Kingdom: Veterinary clinical assessment of 200 cases","volume":"44","author":"J L Ireland","year":"2012","journal-title":"Equine Vet J"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.joca.2010.09.013","article-title":"OARSI-FDA initiative: Defining the disease state of osteoarthritis","volume":"19","author":"N E Lane","year":"2011","journal-title":"Osteoarthr Cartil"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.joca.2012.08.027","article-title":"Synovial inflammation, immune cells and their cytokines in osteoarthritis: A review","volume":"20","author":"B JE de Lange-Brokaar","year":"2012","journal-title":"Osteoarthr Cartil"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.joca.2012.11.012","article-title":"Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!)","volume":"21","author":"F Berenbaum","year":"2013","journal-title":"Osteoarthr Cartil"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/nrrheum.2010.159","article-title":"The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis","volume":"6","author":"J Sellam","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.semcdb.2016.05.009","article-title":"The joint synovium: A critical determinant of articular cartilage fate in inflammatory joint diseases","volume":"62","author":"P Bhattaram","year":"2017","journal-title":"Semin Cell Dev Biol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-017-1229-9","article-title":"Synovitis in osteoarthritis: Current understanding with therapeutic implications","volume":"19","author":"A Mathiessen","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/14728214.2018.1547706","article-title":"Disease-modifying drugs in osteoarthritis: Current understanding and future therapeutics","volume":"23","author":"W M Oo","year":"2018","journal-title":"Expert Opin Emerg Drugs"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.joca.2019.06.011","article-title":"OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis","volume":"27","author":"R R Bannuru","year":"2019","journal-title":"Osteoarthr Cartil"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/art.37908","article-title":"Adipose-derived mesenchymal stem cells exert antiinflammatory effects on chondrocytes and synoviocytes from osteoarthritis patients through prostaglandin E2","volume":"65","author":"C Manferdini","year":"2013","journal-title":"Arthritis Rheum"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.joca.2012.06.003","article-title":"Mesenchymal stem cells secrete factors that inhibit inflammatory processes in short-term osteoarthritic synovium and cartilage explant culture","volume":"20","author":"G M van Buul","year":"2012","journal-title":"Osteoarthr Cartil"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1002\/art.11365","article-title":"Stem cell therapy in a caprine model of osteoarthritis","volume":"48","author":"J M Murphy","year":"2003","journal-title":"Arthritis Rheum"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fvets.2016.00101","article-title":"Cell-based veterinary pharmaceuticals \u2013 Basic legal parameters set by the veterinary pharmaceutical law and the genetic engineering law of the European Union","volume":"3","author":"T Faltus","year":"2016","journal-title":"Front Vet Sci"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/00008505-200110000-00002","article-title":"Platelet-rich plasma (PRP): What is PRP and what is not PRP?","volume":"10","author":"R E Marx","year":"2001","journal-title":"Implant Dent"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1055\/s-0029-1225792","article-title":"Klinische Erfahrungen mit der Anwendung von ACS\/ORTHOKIN\/IRAP beim Pferd","volume":"11","author":"T Weinberger","year":"2008","journal-title":"Pferde Spiegel"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jevs.2016.09.014","article-title":"Evaluation of two protocols using autologous conditioned serum for intra-articular therapy of equine osteoarthritis \u2013 A pilot study monitoring cytokines and cartilage-specific biomarkers","volume":"60","author":"J Lasarzik","year":"2018","journal-title":"J Equine Vet Sci"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0121713","article-title":"Leukocyte inclusion within a platelet rich plasma-derived fibrin scaffold stimulates a more pro-inflammatory environment and alters fibrin properties","volume":"10","author":"E Anitua","year":"2015","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1177\/0363546511417792","article-title":"Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma","volume":"39","author":"E A Sundman","year":"2011","journal-title":"Am J Sports Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2460\/ajvr.75.2.141","article-title":"Evaluation of a single intra-articular injection of autologous protein solution for treatment of osteoarthritis in horses","volume":"75","author":"A L Bertone","year":"2014","journal-title":"Am J Vet Res"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"266","DOI":"10.2460\/ajvr.75.2.141","article-title":"Comparison of growth factor and platelet concentration from commercial platelet-rich plasma separation systems","volume":"39","author":"T N Castillo","year":"2011","journal-title":"Am J Sports Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/evj.12288","article-title":"Equine autologous platelet concentrates: A comparative study between different available systems","volume":"47","author":"L N Hessel","year":"2015","journal-title":"Equine Vet J"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3415\/VCOT-11-01-0001","article-title":"Evaluation of a filter-prepared platelet concentrate for the treatment of suspensory branch injuries in horses","volume":"24","author":"G Castelijns","year":"2011","journal-title":"Vet Comp Orthop Traumatol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1532-950X.2013.12015.x","article-title":"Intra-articular use of a platelet-rich product in normal horses: Clinical signs and cytologic responses","volume":"42","author":"J A Textor","year":"2013","journal-title":"Vet Surg"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"258","DOI":"10.21836\/PEM20120302","article-title":"Biochemische Eigenschaften des equinen autologous conditioned Plasma\u00ae (ACP)","volume":"28","author":"C Kissich","year":"2012","journal-title":"Pferdeheilk"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fvets.2019.00064","article-title":"The effect of autologous protein solution on the inflammatory cascade in stimulated equine chondrocytes","volume":"6","author":"R L Linardi","year":"2019","journal-title":"Front Vet Sci"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"290","DOI":"10.2460\/ajvr.68.3.290","article-title":"Clinical, biochemical, and histologic effects of intra-articular administration of autologous conditioned serum in horses with experimentally induced osteoarthritis","volume":"68","author":"D D Frisbie","year":"2006","journal-title":"Am J Vet Res"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/j.2042-3306.2010.00321.x","article-title":"Autologous conditioned serum: The comparative cytokine profiles of two commercial methods (IRAP and IRAP II) using equine blood","volume":"43","author":"T H Hraha","year":"2011","journal-title":"Equine Vet J"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/j.theriogenology.2010.11.008","article-title":"Markers of stemness in equine mesenchymal stem cells: A plea for uniformity","volume":"75","author":"C De Schauwer","year":"2011","journal-title":"Theriogenology"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/cyto.a.22216","article-title":"Equine cellular therapy \u2013 from stall to bench to bedside?","volume":"83 A","author":"J Burk","year":"2013","journal-title":"Cytom Part A"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/14653240500319234","article-title":"Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement","volume":"7","author":"E M Horwitz","year":"2005","journal-title":"Cytotherapy"},{"key":"ref32","first-page":"155","article-title":"Current and future regenerative medicine \u2013 principles, concepts, and therapeutic use of stem cell therapy and tissue engineering in equine medicine","volume":"50","author":"T G Koch","year":"2009","journal-title":"Can Vet J"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/scrt414","article-title":"Equine mesenchymal stem cells from bone marrow, adipose tissue and umbilical cord: Immunophenotypic characterization and differentiation potential","volume":"5","author":"D J Barberini","year":"2014","journal-title":"Stem Cell Res Ther"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.tvjl.2012.06.004","article-title":"Growth and differentiation characteristics of equine mesenchymal stromal cells derived from different sources","volume":"195","author":"J Burk","year":"2013","journal-title":"Vet J"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"M Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s00018-013-1462-6","article-title":"Natural history of mesenchymal stem cells, from vessel walls to culture vessels","volume":"71","author":"I R Murray","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1126\/science.287.5457.1427","article-title":"Out of eden: Stem cells and their niches","volume":"287","author":"F M Watt","year":"2000","journal-title":"Science"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1161\/01.CIR.0000096485.64373.C5","article-title":"Multilineage potential of cells from the artery wall","volume":"108","author":"Y Tintut","year":"2003","journal-title":"Circulation"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.stem.2008.07.003","article-title":"A perivascular origin for mesenchymal stem cells in multiple human organs","volume":"3","author":"M Crisan","year":"2008","journal-title":"Cell Stem Cell"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.bbrc.2008.01.090","article-title":"Human vascular adventitial fibroblasts contain mesenchymal stem\/progenitor cells","volume":"368","author":"A Hoshino","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1749-6632.2009.04967.x","article-title":"Perivascular multipotent progenitor cells in human organs","volume":"1176","author":"M Crisan","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-017-0525-2","article-title":"Isolation and characterization of equine native MSC populations","volume":"8","author":"C L Esteves","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.2042-3306.2010.00215.x","article-title":"Optimisation of bone marrow aspiration from the equine sternum for the safe recovery of mesenchymal stem cells","volume":"43","author":"Y Kasashima","year":"2011","journal-title":"Equine Vet J"},{"key":"ref44","first-page":"52","article-title":"Comparison of bone marrow aspiration at the sternum and the tuber coxae in middle-aged horses","volume":"76","author":"U Delling","year":"2012","journal-title":"Can J Vet Res"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fvets.2018.00070","article-title":"Cell-based therapies for joint disease in veterinary medicine: What we have learned and what we need to know","volume":"5","author":"S H Bogers","year":"2018","journal-title":"Front Vet Sci"},{"key":"ref46","first-page":"215","volume-title":"Application of stem cells for the treatment of joint disease in horses","author":"W Brehm","year":"2014","edition":"1st ed."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/eve.12398","article-title":"Ultrasound-guided lipoaspiration for mesenchymal stromal cell harvest in the horse","volume":"28","author":"J Lawver","year":"2016","journal-title":"Equine Vet Educ"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-019-1429-0","article-title":"Investigation of stemness and multipotency of equine adipose-derived mesenchymal stem cells (ASCs) from different fat sources in comparison with lipoma","volume":"10","author":"S Arnhold","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.jevs.2014.06.023","article-title":"Characterization of nucleated cells from equine adipose tissue and bone marrow aspirate processed for point-of-care use","volume":"34","author":"I Bruno","year":"2014","journal-title":"J Equine Vet Sci"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"561","DOI":"10.2460\/ajvr.76.6.561","article-title":"System to enhance recovery of equine bone marrow elements","volume":"76","author":"L N Mundy","year":"2015","journal-title":"Am J Vet Res"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1089\/scd.2014.0407","article-title":"Adipose-derived stem cells in veterinary medicine: characterization and therapeutic applications","volume":"24","author":"C Marx","year":"2015","journal-title":"Stem Cells Dev"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1002\/jor.20933","article-title":"Evaluation of adipose-derived stromal vascular fraction or bone marrow-derived mesenchymal stem cells for treatment of osteoarthritis","volume":"27","author":"D D Frisbie","year":"2009","journal-title":"J Orthop Res"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"138","DOI":"10.2106\/JBJS.17.00132","article-title":"Minimally manipulated bone marrow concentrate compared with microfracture treatment of full-thickness chondral defects: A one-year study in an equine model","volume":"100","author":"C R Chu","year":"2018","journal-title":"J Bone Jt Surg Am"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00167-016-3981-9","article-title":"Bone marrow concentrate and platelet-rich plasma differ in cell distribution and interleukin 1 receptor antagonist protein concentration","volume":"26","author":"J M Cassano","year":"2018","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/sctm.18-0020","article-title":"Intra-articular administration of autologous micro-fragmented adipose tissue in dogs with spontaneous osteoarthritis: Safety, feasibility, and clinical outcomes","volume":"7","author":"O Zeira","year":"2018","journal-title":"Stem Cells Transl Med"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1055\/s-0040-1708524","article-title":"Evaluation of a single intra-articular injection of autologous adipose tissue for the treatment of osteoarthritis: A prospective clinical study in dogs","volume":"33","author":"G S Pavarotti","year":"2020","journal-title":"Vet Comp Orthop Traumatol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7717\/peerj.1773","article-title":"Evaluation of transport conditions for autologous bone marrow-derived mesenchymal stromal cells for therapeutic application in horses","volume":"2016","author":"M Espina","year":"2016","journal-title":"PeerJ"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.coph.2018.03.009","article-title":"Stem cell-based therapeutic strategies for cartilage defects and osteoarthritis","volume":"40","author":"C De Bari","year":"2018","journal-title":"Curr Opin Pharmacol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1007\/s00167-018-5118-9","article-title":"Injective mesenchymal stem cell-based treatments for knee osteoarthritis: From mechanisms of action to current clinical evidences","volume":"27","author":"S Lopa","year":"2019","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.tvjl.2014.09.024","article-title":"Stem cell therapies for treating osteoarthritis: Prescient or premature?","volume":"202","author":"D J Whitworth","year":"2014","journal-title":"Vet J"},{"key":"ref62","volume-title":"Turning round: Optimizing the anti-inflammatory properties of equine bone marrow derived mesenchymal stem cells for osteoarthritis through three-dimensional culture [Dissertation]","author":"S H Bogers","year":"2017"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fbioe.2019.00009","article-title":"Mesenchymal stem cell therapy for osteoarthritis: The critical role of the cell secretome","volume":"7","author":"P Mancuso","year":"2019","journal-title":"Front Bioeng Biotechnol"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1002\/sctm.17-0051","article-title":"Mesenchymal stem cells: Time to change the name!","volume":"6","author":"A I Caplan","year":"2017","journal-title":"Stem Cells Transl Med"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0085917","article-title":"Regenerative therapies for equine degenerative joint disease: A preliminary study","volume":"9","author":"S Broeckx","year":"2014","journal-title":"PLoS One"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1159\/000430384","article-title":"Chondrogenic priming at reduced cell density enhances cartilage adhesion of equine allogeneic mscs \u2013 a loading sensitive phenomenon in an organ culture study with 180 explants","volume":"37","author":"J H Spaas","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"ref67","volume-title":"Efficacy and safety study of allogeneic equine umbilical cord derived mesenchymal stem cells (EUC-MSCs) for the treatment of clinical symptomatology associated with mild to moderate degenerative joint disease (osteoarthritis) in horses under field conditions [Dissertation]","author":"A P Mu\u00f1oz","year":"2019"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/jor.20382","article-title":"Enhanced early chondrogenesis in articular defects following arthroscopic mesenchymal stem cell implantation in an equine model","volume":"25","author":"M M Wilke","year":"2007","journal-title":"J Orthop Res"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tvjl.2015.10.027","article-title":"Cell-based cartilage repair strategies in the horse","volume":"208","author":"K F Ortved","year":"2016","journal-title":"Vet J"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1532-950X.2013.12100.x","article-title":"Clinical outcome after intra-articular administration of bone marrow derived mesenchymal stem cells in 33 horses with stifle injury","volume":"43","author":"D J Ferris","year":"2014","journal-title":"Vet Surg"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"779","DOI":"10.2460\/ajvr.77.7.779","article-title":"Assessment of regeneration in meniscal lesions by use of mesenchymal stem cells derived from equine bone marrow and adipose tissue","volume":"77","author":"M L Gonz\u00e1lez-Fern\u00e1ndez","year":"2016","journal-title":"Am J Vet Res"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1089\/ten.TEA.2016.0317","article-title":"Three-dimensional coculture of meniscal cells and mesenchymal stem cells in collagen type I hydrogel on a small intestinal matrix \u2013 A pilot study toward equine meniscus tissue engineering","volume":"23","author":"A Kremer","year":"2017","journal-title":"Tissue Eng Part A"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-015-0077-2","article-title":"Meniscus repair using mesenchymal stem cells \u2013 A comprehensive review","volume":"6","author":"H Yu","year":"2015","journal-title":"Stem Cell Res Ther"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1089\/ten.teb.2014.0034","article-title":"Enhancing chondrogenic phenotype for cartilage tissue engineering: Monoculture and coculture of articular chondrocytes and mesenchymal stem cells","volume":"20","author":"K M Hubka","year":"2014","journal-title":"Tissue Eng Part B Rev"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12917-015-0403-z","article-title":"Platelet-rich plasma in orthopedic therapy: A comparative systematic review of clinical and experimental data in equine and human musculoskeletal lesions","volume":"11","author":"P M Brossi","year":"2015","journal-title":"BMC Vet Res"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"102820","DOI":"10.1016\/j.jevs.2019.102820","article-title":"Platelet-rich products and their application to osteoarthritis","volume":"86","author":"L C Garbin","year":"2020","journal-title":"J Equine Vet Sci"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"646","DOI":"10.2460\/ajvr.80.7.646","article-title":"Effects of blood-derived products and sodium hyaluronate on equine synovial fluid cells and on synovial fluid from osteochondrotic joints of horses after arthroscopy and administration of treatment","volume":"80","author":"T SL Machado","year":"2019","journal-title":"Am J Vet Res"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cveq.2011.05.001","article-title":"Autologous biologic treatment for equine musculoskeletal injuries: platelet-rich plasma and IL-1 receptor antagonist protein","volume":"27","author":"J A Textor","year":"2011","journal-title":"Vet Clin North Am Equine Pract"},{"key":"ref80","first-page":"831","article-title":"Short- and long-term effects of platelet-rich plasma upon healthy equine joints: Clinical and laboratory aspects","volume":"56","author":"A PL Moraes","year":"2015","journal-title":"Can Vet J"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/j.1532-950X.2012.01016.x","article-title":"Activation of equine platelet-rich plasma: Comparison of methods and characterization of equine autologous thrombin","volume":"41","author":"J A Textor","year":"2012","journal-title":"Vet Surg"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.tvjl.2013.07.020","article-title":"Synovial fluid growth factor and cytokine concentrations after intra-articular injection of a platelet-rich product in horses","volume":"198","author":"J A Textor","year":"2013","journal-title":"Vet J"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"356","DOI":"10.21836\/PEM20170405","article-title":"Komplikationen nach intraartikularer Anwendung von ACS (I RAP\u00ae) beim Pferd \u2013 Retrospektive Studie","volume":"33","author":"K Warner","year":"2017","journal-title":"Pferdeheilk"},{"key":"ref84","first-page":"75","article-title":"Comparison of intraarticular injection of autologous conditioned serum (ACS, irap) vs sodium hyaluronate and corticosteroid in front limb coffin joint lameness","volume":"29","author":"U Jostingmeier","year":"2010","journal-title":"Aust Equine Vet"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1080\/01652176.2016.1141257","article-title":"Evaluation of intra-articular injection of autologous platelet lysate (PL) in horses with osteoarthritis of the distal interphalangeal joint","volume":"36","author":"P Tyrnenopoulou","year":"2016","journal-title":"Vet Q"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"195","DOI":"10.21836\/pem20140208","article-title":"Comparison of cellular and growth factor concentrations in equine Autologous Conditioned Plasma\u00ae (ACP) and manually prepared Platelet Rich Plasma (mPRP)","volume":"30","author":"J C Ionita","year":"2014","journal-title":"Pferdeheilk"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.rvsc.2018.03.011","article-title":"Concepts and challenges in the use of mesenchymal stem cells as a treatment for cartilage damage in the horse","volume":"118","author":"M Zayed","year":"2018","journal-title":"Res Vet Sci"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3109\/14653249.2010.536213","article-title":"Clinicopathologic findings following intra-articular injection of autologous and allogeneic placentally derived equine mesenchymal stem cells in horses","volume":"13","author":"D D Carrade","year":"2011","journal-title":"Cytotherapy"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2174\/1574888\u00d709666140826110601","article-title":"Allogenic mesenchymal stem cells as a treatment for equine degenerative joint disease: A pilot study","volume":"9","author":"S Y Broeckx","year":"2014","journal-title":"Curr Stem Cell Res Ther"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/scrt402","article-title":"Equine bone marrow-derived mesenchymal stromal cells are heterogeneous in MHC class II expression and capable of inciting an immune response in vitro","volume":"5","author":"L V Schnabel","year":"2014","journal-title":"Stem Cell Res Ther"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-015-0053-x","article-title":"Equine allogeneic bone marrow-derived mesenchymal stromal cells elicit antibody responses in vivo","volume":"6","author":"L M Pezzanite","year":"2015","journal-title":"Stem Cell Res Ther"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1089\/scd.2016.0266","article-title":"Autologous and allogeneic equine mesenchymal stem cells exhibit equivalent immunomodulatory properties in vitro","volume":"26","author":"A C Colbath","year":"2017","journal-title":"Stem Cells Dev"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"867","DOI":"10.2460\/ajvr.78.7.867","article-title":"Antigenicity of mesenchymal stem cells in an inflamed joint environment","volume":"78","author":"J A Hill","year":"2017","journal-title":"Am J Vet Res"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"5830103","DOI":"10.1155\/2016\/5830103","article-title":"Allogeneic mesenchymal stem cell treatment induces specific alloantibodies in horses","volume":"2016","author":"S D Owens","year":"2016","journal-title":"Stem Cells Int"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.vetimm.2013.09.003","article-title":"Investigation of the immune response to autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses","volume":"156","author":"J H Pigott","year":"2013","journal-title":"Vet Immunol Immunopathol"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.rvsc.2017.12.018","article-title":"Equine allogeneic chondrogenic induced mesenchymal stem cells: A GCP target animal safety and biodistribution study","volume":"117","author":"S Y Broeckx","year":"2018","journal-title":"Res Vet Sci"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/evj.13089","article-title":"The use of equine chondrogenic-induced mesenchymal stem cells as a treatment for osteoarthritis: A randomised, double-blinded, placebo-controlled proof-of-concept study","volume":"51","author":"S Y Broeckx","year":"2019","journal-title":"Equine Vet J"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1089\/scd.2018.0061","article-title":"Equine allogeneic chondrogenic induced mesenchymal stem cells are an effective treatment for degenerative joint disease in horses","volume":"28","author":"S Y Broeckx","year":"2019","journal-title":"Stem Cells Dev"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1042\/cbi20090211","article-title":"Effects of non-steroidal anti-inflammatory drugs on proliferation, differentiation and migration in equine mesenchymal stem cells","volume":"35","author":"M M\u00fcller","year":"2011","journal-title":"Cell Biol Int"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1089\/ten.TEA.2012.0129","article-title":"Effect of acetaminophen and nonsteroidal anti-inflammatory drugs on gene expression of mesenchymal stem cells","volume":"19","author":"A Almaawi","year":"2013","journal-title":"Tissue Eng Part A"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13287-017-0503-8","article-title":"Repeated intra-articular injection of allogeneic mesenchymal stem cells causes an adverse response compared to autologous cells in the equine model","volume":"8","author":"A J Joswig","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1679\/aohc.63.17","article-title":"Morphology and functional roles of synoviocytes in the joint","volume":"63","author":"T Iwanaga","year":"2000","journal-title":"Arch Histol Cytol"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"904","DOI":"10.2106\/JBJS.18.00915","article-title":"International expert consensus on a cell therapy communication tool: DOSES","volume":"101","author":"I R Murray","year":"2019","journal-title":"J Bone Jt Surg Am"}],"container-title":["Tier\u00e4rztliche Praxis Ausgabe G: Gro\u00dftiere \/ Nutztiere"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1482-7752.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T22:33:44Z","timestamp":1624401224000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1482-7752"}},"subtitle":["Grundlagenwissen f\u00fcr den Praktiker"],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":100,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2021,6,22]]},"published-print":{"date-parts":[[2021,6]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1482-7752","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1434-1220","2567-5834"],"issn-type":[{"value":"1434-1220","type":"print"},{"value":"2567-5834","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6]]}}}